Suppr超能文献

低成本微流体混合器:它们能胜任这项任务吗?

Low-Cost Microfluidic Mixers: Are They up to the Task?

作者信息

Forrester Jade, Davidson Callum G, Blair May, Donlon Lynn, McLoughlin Daragh M, Obiora Chukwuebuka R, Stockdale Heather, Thomas Ben, Nutman Martina, Brockbank Sarah, Rattray Zahra, Perrie Yvonne

机构信息

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.

Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK.

出版信息

Pharmaceutics. 2025 Apr 25;17(5):566. doi: 10.3390/pharmaceutics17050566.

Abstract

: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). : This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. : The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70-100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. : Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.

摘要

微流控混合已成为制造基于核酸脂质的递送系统的金标准程序,可对关键工艺参数进行精确控制。微流控混合器的选择和设计通常被视为影响所得脂质纳米颗粒(LNP)关键质量属性的关键驱动力。

本研究旨在评估使用两种低成本微流控混合器以及手动混合(移液管混合(PM))制造的LNP,随后进行使用正交分析的表征研究以及表达研究,以确定低成本微流控制造方法是否适用于实验室规模和高通量研究。

结果表明,所有制造方法都可以生产尺寸在95至215纳米之间、具有高封装率(70 - 100%)的LNP,增强分析显示使用不同混合器生产的LNP之间存在差异。尽管存在这些差异,但通过移液管混合生产LNP证明了其作为LNP高通量筛选工具的应用,能够有效区分不同配方并预测体外和体内的一致表达模式。

总体而言,这些结果验证了低成本微流控混合器的使用,同时不影响所得LNP的效率和完整性。本研究支持了小规模LNP制造和高通量筛选的更高可及性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/842da3fe696f/pharmaceutics-17-00566-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验